Top Markets
Coin of the day
Lytix Biopharma AS Lytix Biopharma AS

Lytix Biopharma AS

LYTIX
Classement en actions #24454
Based in Oslo, Norway, Lytix Biopharma ASA is a clinical-stage biotechnology... Based in Oslo, Norway, Lytix Biopharma ASA is a clinical-stage biotechnology firm dedicated to advancing innovative immunotherapies for cancer treatment. Its primary drug candidate, LTX-315, is an oncolytic molecule currently undergoing Phase II clinical trials. This therapy is formulated for intratumoral injection, aiming to provide localized treatment for solid tumors. Additionally, Lytix Biopharma is developing LTX-401, another oncolytic molecule in its preclinical phase, specifically designed to target deep-seated cancerous lesions, including those found in liver cancer. The company was established in 2003.
Prix de l'action
$0.78611575
Capitalisation boursière
$60.45M
Changement (1 jour)
0.00%
Changement (1 an)
-12.06%
Pays
NO
Échange Lytix Biopharma AS (LYTIX)

Catégorie

Le prix LYTIX avec la capitalisation boursière de B
Lytix Biopharma AS Lytix Biopharma AS
LYTIX
$0.78611575
Capitalisation boursière de Lytix Biopharma AS(LYTIX)
Capitalisation boursière: $60.45M
En August 2026, Lytix Biopharma AS a une capitalisation boursière de $60.45M. Cela fait de Lytix Biopharma AS la 24454th entreprise la plus valorisée au monde selon nos données. La capitalisation boursière, souvent appelée market cap, correspond à la valeur totale des actions en circulation d’une entreprise cotée en bourse, et est couramment utilisée pour évaluer sa valeur.
Historique de la capitalisation boursière de Lytix Biopharma AS du 2021 au 2026
LYTIX par rapport au top 5 des plus populaires stocks
Prix pour LYTIX L’actif B La capitalisation boursière de B Résultats
Lytix Biopharma AS Lytix Biopharma AS
$67,754.55 $60.45M
$5.210T +8,618,802.12%
Lytix Biopharma AS Lytix Biopharma AS
$59,123.77 $60.45M
$4.547T +7,520,900.56%
Lytix Biopharma AS Lytix Biopharma AS
$53,939.86 $60.45M
$4.148T +6,861,466.80%
Lytix Biopharma AS Lytix Biopharma AS
$46,497.08 $60.45M
$3.576T +5,914,688.66%
Lytix Biopharma AS Lytix Biopharma AS
$36,143.30 $60.45M
$2.779T +4,597,606.72%